（1）Shi PJ#, Xu LH# , Lin KY, Weng WJ, Fang JP. Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia. J Hematol Oncol 2016;9(1):12. (#Equal contribution authors). （IF=6.263） （2）Xu LH, Fang JP, Weng WJ, Huang K, Guo HX, Liu Y, Zhang JH. Pure red cell aplasia associated with cytomegalovirus and Epstein-Barr virus infection in 7 cases of Chinese children. Hematology 2013;18(1):56-59.（IF= 1.385） （3）Xu LH, Fang JP, Weng WJ, Huang K, Guo HX, Liu Y, Zhang JH. Pure red cell aplasia associated with cytomegalovirus and Epstein-Barr virus infection in 7 cases of Chinese children. Hematology 2013;18(1):56-59. （IF= 1.385） （4）Xu LH, Fang JP, Weng WJ, Huang K, Zhang YT. Autoimmune hemolytic anemia in patients with β-thalassemia major. Pediatr Hematol Oncol 2012;29(3):235- 240. （IF= 1.090） （5）Xu LH, Fang JP, Huang WG, Xu HG, Weng WJ, Kao GS, Le Y. Marrow graft rejection by repeated transfusions of allogeneic donor spleen cells. Bone Marrow Transplant 2007; 40(7): 691-698. （IF= 3.636）
